April 2, 2018 | GEN News Highlights AstraZeneca’s #MedImmune subsidiary has agreed to exclusively license and develop #bispecific and multispecific #immuno-oncology antibody products from Compugen’s pipeline, through a collaboration that #Compugen said today…
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced #clinical trials Lilach Baumer17:4228.03.18 Pharmaceutical company InSight Biopharmaceuticals Ltd. has signed a…
The ambitious plan is designed to make Israel a digital health power and improve the health of its residents, and of the entire world. Israel's cabinet today approved a NIS…
Google (NSDQ:GOOG) is taking its Cloud services into the field of healthcare as it aims to enable data sharing and collaboration between providers and patients, according to a recent blog post…
Ness Ziona-based MyBiotics has developed techniques that can reliably restore microbiome equilibrium. Ness Ziona-based microbiome therapeutics company MyBiotics Pharma Ltd. has entered into a second option agreement with Ferring Holding Ltd. for the…
by Nick Paul Taylor | Feb 26, 2018 10:00am #Biosensorix has formed a collaboration with #BGNTechnologies to develop point-of-care diagnostics. The alliance with the technology transfer firm gives Biosensorix access to an #electrochemical lateral…
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a…
Israel’s first Innovation Lab for Healthy Aging has been launched in Beersheva, simulating the challenges in the everyday living environment of senior citizens in order to inspire solutions. The new…
An electricity-conducting, environment-sensing, shape-changing machine the size of a human cell? Is that even possible? Cornell physicists Paul McEuen and Itai Cohen not only say yes, but they’ve actually built the “muscle” for…
DreaMed Diabetes's cloud-based Advisor Pro helps doctors craft or modify insulin plans based on 288 daily glucose level readings By URVASHI VERMA 21 | February 2018, 12:52 pm Petah Tikva-based DreaMed Diabetes has developed…